📰 Nasdaq Cdmo News
Page 3 - Nasdaq Cdmo News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Nasdaq Cdmo. Real-time updates on events, politics, business and more.
August 1, 2023
Scissortail Wealth Management LLC acquired a new position in Avid Bioservices, Inc. (NASDAQ:CDMO – Free Report) in the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 1,867 shares of the biopharmaceutical company’s stock, valued at approximately $304,617,000. Other large investors have […]
July 24, 2023
Avid Bioservices, Inc. (NASDAQ:CDMO – Get Free Report) shares dropped 5% during trading on Monday . The company traded as low as $13.21 and last traded at $13.21. Approximately 163,575 shares traded hands during mid-day trading, a decline of 71% from the average daily volume of 573,647 shares. The stock had previously closed at $13.91. […]
June 27, 2023
Avid Bioservices, Inc. (NASDAQ:CDMO – Get Rating) – Equities research analysts at KeyCorp lowered their FY2024 earnings per share estimates for shares of Avid Bioservices in a report released on Wednesday, June 21st. KeyCorp analyst P. Knight now forecasts that the biopharmaceutical company will earn ($0.07) per share for the year, down from their previous […]
June 26, 2023
Avid Bioservices (NASDAQ:CDMO – Get Rating) had its price target lowered by Stephens from $24.00 to $20.00 in a report released on Thursday, The Fly reports. Separately, Royal Bank of Canada restated an outperform rating and set a $20.00 target price on shares of Avid Bioservices in a research report on Tuesday, March 14th. Avid […]
June 25, 2023
Avid Bioservices (NASDAQ:CDMO – Get Rating) had its target price reduced by Royal Bank of Canada from $20.00 to $17.00 in a research note issued to investors on Thursday morning, The Fly reports. Separately, Stephens reduced their price objective on shares of Avid Bioservices from $24.00 to $20.00 in a research note on Thursday. Avid […]
June 24, 2023
Avid Bioservices (NASDAQ:CDMO – Get Rating) had its price objective lowered by Stephens from $24.00 to $20.00 in a research report issued to clients and investors on Thursday, The Fly reports. Stephens’ target price suggests a potential upside of 49.93% from the company’s current price. Separately, Royal Bank of Canada reaffirmed an “outperform” rating and […]
May 3, 2023
Avid Bioservices, Inc. (NASDAQ:CDMO – Get Rating) Director Richard B. Hancock sold 5,000 shares of the firm’s stock in a transaction that occurred on Monday, May 1st. The stock was sold at an average price of $17.92, for a total value of $89,600.00. Following the transaction, the director now owns 39,134 shares in the company, […]
May 2, 2023
Geneva Capital Management LLC increased its holdings in Avid Bioservices, Inc. (NASDAQ:CDMO – Get Rating) by 27.5% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 1,836,781 shares of the biopharmaceutical company’s stock after buying an additional 396,417 shares […]
April 15, 2023
Avid Bioservices, Inc. (NASDAQ:CDMO – Get Rating) CEO Nicholas Stewart Green sold 7,000 shares of the firm’s stock in a transaction on Thursday, April 13th. The stock was sold at an average price of $20.92, for a total value of $146,440.00. Following the transaction, the chief executive officer now owns 83,531 shares in the company, […]
April 14, 2023
Avid Bioservices, Inc. (NASDAQ:CDMO – Get Rating) was down 6% during mid-day trading on Friday . The stock traded as low as $19.63 and last traded at $19.67. Approximately 237,027 shares were traded during mid-day trading, a decline of 59% from the average daily volume of 584,865 shares. The stock had previously closed at $20.93. […]